YieldTerminal Pro's November 4 Premarket Map reviews five stories from company filings, news reporting, and a recorded early premarket snapshot. The full video combines the approved Shorts. The dated price charts use completed daily candles through the November 3 regular-session close. Premarket moves were separate observations and are not continuously updated prices.
Super Micro: preliminary figures
Super Micro called its fiscal first-quarter results preliminary and unaudited. The company said its quarter-end closing procedures were incomplete, actual results could differ materially, and its outside auditor had not audited or reviewed the preliminary numbers. It reported net sales above $19.9 billion. The early premarket observation showed the shares higher than Tuesday's close; the chart's daily candle remains the November 3 close.
See the Super Micro Short and the company's SEC-filed release.
Arista: revenue growth
Arista reported third-quarter revenue growth of 58.5% from a year earlier and said revenue rose 20.5% from the second quarter. Product revenue exceeded $3.1 billion, up more than 66% year over year. The company reported a 49.1% adjusted operating margin and guided to $3.9 billion to $4.0 billion of fourth-quarter revenue. The chart marks the $169.91 November 3 close, before the report, and its 50-day and 200-day averages.
See the Arista Short and the company's SEC-filed results.
Block and Toast: similar growth, different early moves
Block and Toast each raised their full-year outlooks after reporting third-quarter results. Block's gross profit grew 21.56% year over year; Toast's revenue grew 21.31%. In the recorded early premarket snapshot, Block was higher and Toast lower. That price contrast is an observation, not evidence that either outlook caused the move.
Watch the Block and Toast Short. Read Block's shareholder letter and Toast's results release.
CVS: proposed separation
CVS said it intends to separate into two independent, publicly traded companies: a healthcare solutions company called CVS Health for now and a retail pharmacy company to be named CVS Pharmacy. It raised full-year adjusted EPS guidance to at least $8.20. Third-quarter adjusted EPS was $2.09, up from $1.60 a year earlier; revenue was $108.4 billion, up 5.4%; the medical benefit ratio fell to 91.3% from 92.8%. The chart shows the $91.41 November 3 close before these announcements.
See the CVS Short, the results exhibit and the separation announcement.
SpaceX after the midterms
SpaceX traded lower in a recorded early premarket observation after the midterm election. CBS News projected Democratic control of the House and Senate. A Stocktwits report carried by Yahoo Finance discussed fears of political backlash, while TipRanks cited an investor-services executive on possible scrutiny of a Tesla-SpaceX merger. These are reported explanations, not a confirmed cause of the price move. The chart is based on completed daily bars through November 3.
Watch the SpaceX Short.
Explore Daily Levels, the November 3 After-Close Map, and the free weekly newsletter. This is market research only, not a recommendation to buy or sell.